Flat Panel Detector
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Food and Drug Administration (FDA), specifically the Center for Devices and Radiological Health (CDRH), has issued a Request for Information (RFI) for market research purposes. The agency seeks sources capable of providing one (1) large-area 2D X-ray flat panel detector to support laboratory cone-beam CT (CBCT) and fluoroscopy imaging for human-sized phantom development, testing, and validation. Responses are due May 22, 2026, at 5:00 PM Eastern Time.
Scope of Requirement
The FDA requires a flat panel detector with specific technical requirements, including:
- Active Imaging Area: ≥ 42.7 cm × 42.7 cm
- Pixel Pitch: ≤ 170 µm
- MTF: ≥ 50% at 1 lp/mm
- DQE: ≥ 70% at 0 lp/mm
- Lag: ≤ 3% (first frame)
- Energy Range: 40–150 kVp (or wider)
- Fluoroscopy Mode: ≥ 25 fps at ~3×3 binning, large FOV
- CBCT Projection Mode: ≥ 40 fps at ~4×4 binning
- Radiography (Full Res): ≥ 4 fps
- Cooling: Air cooling only
- Radiation Tolerance: ≥ 2,000 Gy (active area)
- Weight: ≤ 15 kg
- Warranty & Support: Minimum 1 year warranty and 1 year remote technical support.
Requested Information from Vendors
Interested vendors should provide company details (name, address, CAGE, UEI), business size under NAICS 334510, product name/model, confirmation of meeting technical requirements, estimated unit price range, delivery lead time, and standard warranty/support options. Any exceptions or deviations should also be noted. Responses should be concise, 5 pages or less.
Contract & Timeline
- Type: Sources Sought / Request for Information (RFI)
- Set-Aside: None specified (market research)
- Response Due: May 22, 2026, 5:00 PM Eastern Time
- Published: May 15, 2026
- Submission: Via email to Freshta.Javid@fda.hhs.gov, referencing RFI Number CDRH-2026-133668 in the subject line.
Additional Notes
This RFI is for informational and planning purposes only and does not constitute a solicitation or commitment to award a contract. Responses are voluntary, and no reimbursement will be provided.